Filing Manager
Omega Fund VI, L.P.
Reporting Manager
Omega Fund VI, L.P.
Symbol
LXEO
Shares outstanding
32,906,556 shares
Disclosed Ownership
1,184,636 shares
Ownership
3.6%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 09:00:03 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"Omega Fund VI, L.P. disclosed 3.6% ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO) on 31 Dec 2024."

Quick Takeaways

  • Omega Fund VI, L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO).
  • Disclosed ownership: 3.6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 09:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Omega Fund VI, L.P. 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Director of General Partner of General Partner
Omega Fund VI GP, L.P. 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Director of General Partner
Omega Fund VI GP Manager, Ltd. 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Director
Claudio Nessi 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Attorney-in-Fact
Otello Stampacchia 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia
Francesco Draetta 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Attorney-in-Fact